Drug Type Small molecule drug |
Synonyms SPD 535, SPD-535 |
Target |
Action inhibitors |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H11Cl2N3O |
InChIKeyIGMDPBNGNRHCRW-UHFFFAOYSA-N |
CAS Registry1029711-88-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Phase 2 | United Kingdom | - | |
| Thrombosis | Phase 2 | - | - |





